Hepatitis B and C viruses (HBV and HCV) are significant causes of chronic liver diseases, with approximately 350 million infections globally. To accelerate the finding of effective treatment options, ...
Rockefeller University researchers have identified a late-stage viral entry block that stops hepatitis B virus (HBV) from infecting mouse liver cells, overturning long-held assumptions. This discovery ...
Hepatitis B virus (HBV) remains a major global health concern, with sexual transmission being a key driver among adults. This study develops a gender-stratified compartmental model of HBV spread that ...
A new prognostic model could potentially predict and stratify the risk for hepatocellular carcinoma (HCC) among patients with chronic hepatitis B (CHB) who are noncirrhotic and not indicated for ...
Some 254 million people live with a chronic hepatitis B (HBV) infection that is often asymptomatic for decades, only to emerge in an advanced stage of disease that turns to fatal cirrhosis or liver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results